Point-of-care coagulation management in intensive care medicine

Critical Care

Volumn 17, Issue 2, 2013, Pages

  Meybohm, Patrick ^a   Zacharowski, Kai ^a   Weber, Christian F ^a  

^a UNIVERSITY HOSPITAL FRANKFURT   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ARGATROBAN; BLOOD CLOTTING FACTOR 13 CONCENTRATE; C REACTIVE PROTEIN; DABIGATRAN; DALTEPARIN; DESMOPRESSIN; ENOXAPARIN; FIBRINOGEN; FIBRINOGEN CONCENTRATE; FONDAPARINUX; FRESH FROZEN PLASMA; HEPARIN; HIRULOG; INTERLEUKIN 6; LEPIRUDIN; LOW MOLECULAR WEIGHT HEPARIN; PROTAMINE; PROTHROMBIN COMPLEX; RECOMBINANT BLOOD CLOTTING FACTOR 7A; RIVAROXABAN; ANTICOAGULANT AGENT;

ANTICOAGULANT THERAPY; BLEEDING; BLOOD CLOTTING DISORDER; BLOOD CLOTTING PARAMETERS; BLOOD TRANSFUSION; CARDIOVASCULAR SURGERY; CLINICAL EFFECTIVENESS; CRITICALLY ILL PATIENT; DISEASE SEVERITY; ECONOMIC ASPECT; FIBRINOLYSIS; HEALTH CARE COST; HEMOSTASIS; HOSPITAL ADMISSION; HUMAN; HYPOFIBRINOGENEMIA; INTENSIVE CARE; LIVER TRANSPLANTATION; MORTALITY; PARTIAL THROMBOPLASTIN TIME; PATIENT CARE; PATIENT MONITORING; POINT OF CARE TESTING; POSTOPERATIVE PERIOD; PRIORITY JOURNAL; PROTHROMBIN TIME; RANDOMIZED CONTROLLED TRIAL (TOPIC); REVIEW; SEPSIS; SURGICAL RISK; SURVIVAL; THROMBOCYTE COUNT; THROMBOCYTE FUNCTION; THROMBOCYTOPENIA; THROMBOELASTOGRAPHY; VISCOELASTICITY; ANIMAL; BLOOD CLOTTING; DISEASE MANAGEMENT; DRUG EFFECTS; HOSPITAL INFORMATION SYSTEM; PHYSIOLOGY; PROCEDURES;

ANIMALS; ANTICOAGULANTS; BLOOD COAGULATION; DISEASE MANAGEMENT; HUMANS; INTENSIVE CARE; POINT-OF-CARE SYSTEMS;

EID: 84875365777     PISSN: 13648535     EISSN: 1466609X     Source Type: Journal    
DOI: 10.1186/cc12527     Document Type: Review

References (42)

1. Levi M, Opal SM. Coagulation abnormalities in critically ill patients. Crit Care 2006, 10:222. 10.1186/cc4975, 1750988, 16879728.
2. Glance LG, Dick AW, Mukamel DB, Fleming FJ, Zolla RA, Wissler R, Salloum R, Meredith UW, Osler TM. Association between intraoperative blood transfusion and mortality and morbidity in patients undergoing noncardiac surgery. Anesthesiology 2011, 114:283-292. 10.1097/ALN.0b013e3182054d06, 21239971.
3. Murphy GJ, Reeves BC, Rogers CA, Rizvi SI, Culliford L, Angelini GD. Increased mortality, postoperative morbidity, and cost after red blood cell transfusion in patients having cardiac surgery. Circulation 2007, 116:2544-2552. 10.1161/CIRCULATIONAHA.107.698977, 17998460.
4. Gorlinger K, Bergmann L, Dirkmann D. Coagulation management in patients undergoing mechanical circulatory support. Best Pract Res Clin Anaesthesiol 2012, 26:179-198. 10.1016/j.bpa.2012.04.003, 22910089.
5. Kozek-Langenecker S. Management of massive operative blood loss. Minerva Anestesiol 2007, 73:401-415.
6. Haas T, Spielmann N, Mauch J, Madjdpour C, Speer O, Schmugge M, Weiss M. Comparison of thromboelastometry (ROTEM(R)) with standard plasmatic coagulation testing in paediatric surgery. Br J Anaesth 2012, 108:36-41. 10.1093/bja/aer342, 22086509.
7. Toulon P, Ozier Y, Ankri A, Fleron MH, Leroux G, Samama CM. Point-of-care versus central laboratory coagulation testing during haemorrhagic surgery. A multicenter study. Thromb Haemost 2009, 101:394-401.
8. Jambor C, von Pape KW, Spannagl M, Dietrich W, Giebl A, Weisser H. Multiple electrode whole blood aggregometry, PFA-100, and in vivo bleeding time for the point-of-care assessment of aspirin-induced platelet dysfunction in the preoperative setting. Anesth Analg 2011, 113:31-39. 10.1213/ANE.0b013e31821acddc, 21519054.
9. Hartert H. Thrombelastography, a method for physical analysis of blood coagulation. Z Gesamte Exp Med 1951, 117:189-203. 10.1007/BF02044776, 14836887.
10. Avidan MS, Alcock EL, Da Fonseca J, Ponte J, Desai JB, Despotic GJ, Hunt BJ. Comparison of structured use of routine laboratory tests or near-patient assessment with clinical judgement in the management of bleeding after cardiac surgery. Br J Anaesth 2004, 92:178-186. 10.1093/bja/aeh037, 14722166.
11. Ak K, Isbir CS, Tetik S, Atalan N, Tekeli A, Aljodi M, Civelek A, Arsan S. Thromboelastography-based transfusion algorithm reduces blood product use after elective CABG: a prospective randomized study. J Card Surg 2009, 24:404-410. 10.1111/j.1540-8191.2009.00840.x, 19583608.
12. Westbrook AJ, Olsen J, Bailey M, Bates J, Scully M, Salamonsen RF. Protocol based on thromboelastograph (TEG) out-performs physician preference using laboratory coagulation tests to guide blood replacement during and after cardiac surgery: a pilot study. Heart Lung Circ 2009, 18:277-288. 10.1016/j.hlc.2008.08.016, 19117801.
13. Weber CF, Gorlinger K, Meininger D, Hermann E, Bingold T, Moritz A, Cohn LH, Zacharowski K. Point-of-care testing: A prospective, randomized clinical trial of efficacy in coagulopathic cardiac surgery patients. Anesthesiology 2012, 117:531-547. 10.1097/ALN.0b013e318264c644, 22914710.
14. Nuttall GA, Oliver WC, Santrach PJ, Bryant S, Dearani JA, Schaff HV, Ereth MH. Efficacy of a simple intraoperative transfusion algorithm for nonerythrocyte component utilization after cardiopulmonary bypass. Anesthesiology 2001, 94:773-781. 10.1097/00000542-200105000-00014, 11388527.
15. Gorlinger K, Dirkmann D, Hanke AA, Kamler M, Kottenberg E, Thielmann M, Jakob H, Peters J. First-line therapy with coagulation factor concentrates combined with point-of-care coagulation testing is associated with decreased allogeneic blood transfusion in cardiovascular surgery: a retrospective, single-center cohort study. Anesthesiology 2011, 115:1179-1191.
16. Wang SC, Shieh JF, Chang KY, Chu YC, Liu CS, Loong CC, Chan KH, Mandell S, Tsou MY. Thromboelastography-guided transfusion decreases intraoperative blood transfusion during orthotopic liver transplantation: randomized clinical trial. Transplant Proc 2010, 42:2590-2593. 10.1016/j.transproceed.2010.05.144, 20832550.
17. Gorlinger K. Coagulation management during liver transplantation. Hamostaseologie 2006, 26:S64-S76.
18. Gorlinger K, Fries D, Dirkmann D, Weber CF, Hanke AA, Schochl H. Reduction of fresh frozen plasma requirements by perioperative point-of-care coagulation management with early calculated goal-directed therapy. Transfus Med Hemother 2012, 39:104-113. 10.1159/000337186, 3364099, 22670128.
19. Stainsby D, MacLennan S, Thomas D, Isaac J, Hamilton PJ. Guidelines on the management of massive blood loss. Br J Haematol 2006, 135:634-641.
20. Sarani B, Dunkman WJ, Dean L, Sonnad S, Rohrbach JI, Gracias VH. Transfusion of fresh frozen plasma in critically ill surgical patients is associated with an increased risk of infection. Crit Care Med 2008, 36:1114-1118. 10.1097/CCM.0b013e318168f89d, 18379235.
21. Watson GA, Sperry JL, Rosengart MR, Minei JP, Harbrecht BG, Moore EE, Cuschieri J, Maier RV, Billiar TR, Peitzman AB, . Inflammation and Host Response to Injury Investigators Fresh frozen plasma is independently associated with a higher risk of multiple organ failure and acute respiratory distress syndrome. J Trauma 2009, 67:221-227. 10.1097/TA.0b013e3181ad5957, 19667872, Inflammation and Host Response to Injury Investigators.
22. Maegele M, Lefering R, Yucel N, et al. Early coagulopathy in multiple injury: an analysis from the German Trauma Registry on 8724 patients. Injury 2007, 38:298-304. 10.1016/j.injury.2006.10.003, 17214989.
23. Rourke C, Curry N, Khan S, et al. Fibrinogen levels during trauma hemorrhage, response to replacement therapy, and association with patient outcomes. J Thromb Haemost 2012, 10:1342-1351. 10.1111/j.1538-7836.2012.04752.x, 22519961.
24. Holcomb JB, Minei KM, Scerbo ML, Radwan ZA, Wade CE, Kozar RA, Gill BS, Albarado R, McNutt MK, Khan S, Adams PR, McCarthy JJ, Cotton BA. Admission rapid thrombelastography can replace conventional coagulation tests in the emergency department: experience with 1974 consecutive trauma patients. Ann Surg 2012, 256:476-486. 10.1097/SLA.0b013e3182658180, 22868371.
25. Schochl H, Nienaber U, Hofer G, Voelckel W, Jambor C, Scharbert G, kozek-Lagenecker S, Solomon C. Goal-directed coagulation management of major trauma patients using thromboelastometry (ROTEM)-guided administration of fibrinogen concentrate and prothrombin complex concentrate. Crit Care 2010, 14:R55. 10.1186/cc8948, 2887173, 20374650.
26. Afshari A, Wikkelso A, Brok J, Moller AM, Wetterslev J. Thrombelastography (TEG) or thromboelastometry (ROTEM) to monitor haemotherapy versus usual care in patients with massive transfusion. Cochrane Database Syst Rev 2011, CD007871.
27. Adamzik M, Eggmann M, Frey UH, Görlinger K, Bröcker-Preuss M, Marggraf G, Saner F, Eggebrecht H, Peters J, Hartmann M. Comparison of thromboelastometry with procalcitonin, interleukin 6, and C-reactive protein as diagnostic tests for severe sepsis in critically ill adults. Crit Care 2010, 14:R178. 10.1186/cc9284, 3219282, 20929576.
28. Adamzik M, Langemeier T, Frey UH, Göttinger K, Saner F, Eggebrecht H, Peters J, Hartmann M. Comparison of thrombelastometry with simplified acute physiology score II and sequential organ failure assessment scores for the prediction of 30-day survival: a cohort study. Shock 2011, 35:339-342. 10.1097/SHK.0b013e318204bff6, 21068699.
29. Spalding GJ, Hartrumpf M, Sierig T, Oesberg N, Kirschke CG, Albes JM. Cost reduction of perioperative coagulation management in cardiac surgery: value of "bedside" thrombelastography (ROTEM). Eur J Cardiothorac Surg 2007, 31:1052-1057. 10.1016/j.ejcts.2007.02.022, 17398108.
30. Crowther MA, Warkentin TE. Bleeding risk and the management of bleeding complications in patients undergoing anticoagulant therapy: focus on new anticoagulant agents. Blood 2008, 111:4871-4879. 10.1182/blood-2007-10-120543, 18309033.
31. Hiippala ST, Myllyla GJ, Vahtera EM. Hemostatic factors and replacement of major blood loss with plasma-poor red cell concentrates. Anesth Analg 1995, 81:360-365.
32. Bolliger D, Gorlinger K, Tanaka KA. Pathophysiology and treatment of coagulopathy in massive hemorrhage and hemodilution. Anesthesiology 2010, 113:1205-1219. 10.1097/ALN.0b013e3181f22b5a, 20881594.
33. Warmuth M, Mad P, Wild C. Systematic review of the efficacy and safety of fibrinogen concentrate substitution in adults. Acta Anaesthesiol Scand 2012, 56:539-548. 10.1111/j.1399-6576.2011.02586.x, 22150561.
34. Dickneite G, Pragst. Prothrombin complex concentrate vs fresh frozen plasma for reversal of dilutional coagulopathy in a porcine trauma model. Br J Anaesth 2009, 102:345-354. 10.1093/bja/aen391, 2642652, 19168856.
35. Scharbert G, Kalb M, Marschalek C, Kozek-Langenecker SA. The effects of test temperature and storage temperature on platelet aggregation: a whole blood in vitro study. Anesth Analg 2006, 102:1280-1284. 10.1213/01.ane.0000199399.04496.6d, 16551937.
36. Rinder CS, Mathew JP, Rinder HM, Bonan J, Ault KA, Smith BR. Modulation of platelet surface adhesion receptors during cardiopulmonary bypass. Anesthesiology 1991, 75:563-570. 10.1097/00000542-199110000-00004, 1718190.
37. Picker SM. In vitro assessment of platelet function. Transfus Apher Sci 2011, 44:305-319. 10.1016/j.transci.2011.03.006, 21601530.
38. Lethagen S. Desmopressin (DDAVP) and hemostasis. Ann Hematol 1994, 69:173-180. 10.1007/BF02215950, 7948303.
39. Cauwenberghs S, van Pampus E, Curvers J, Akkerman JW, Heemskerk JW. Hemostatic and signaling functions of transfused platelets. Transfus Med Rev 2007, 21:287-294. 10.1016/j.tmrv.2007.05.004, 17900490.
40. Korte W. F. XIII in perioperative coagulation management. Best Pract Res Clin Anaesthesiol 2010, 24:85-93. 10.1016/j.bpa.2009.09.011, 20402172.
41. Yank V, Tuohy CV, Logan AC, Bravata DM, Staudenmayer K, Eisenhut R, Sundaram V, McMahon D, Olkin I, McDonald KM, Owens DK, Stafford RS. Systematic review: benefits and harms of in-hospital use of recombinant factor VIIa for off-label indications. Ann Intern Med 2011, 154:529-540.
42. Shander A, Van Aken H, Colomina MJ, Gombotz H, Hoffman A, Krauspe R, Lasocki S, Richards T, Slappendel R, Spahn DR. Patient blood management in Europe. Br J Anaesth 2012, 109:55-68. 10.1093/bja/aes139, 3374574, 22628393.